Please assess the completion status of the following clinical trial:

Trial Title: A Safety and Tolerability Study of JNJ-42160443 in Patients With Moderate to Severe, Chronic Knee Pain From Osteoarthritis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~* Clinical diagnosis of osteoarthritis of the knee~* Have moderate to severe pain based on a trial questionnaire~* Must be on a stable dose of pain medication for 4 weeks before entering the trial~* Medically stable condition~Exclusion Criteria:~* History of joint replacement surgery in the affected joint or planned surgery involving the affected joint during the trial~* Diabetes mellitus~* Uncontrolled cardiovascular disease or hypertension~* Previous treatment with another investigational NGF inhibitor therapy

- Gender: ALL
- Minimum Age: 40 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- JNJ-42160443 (lower dose) (Type: EXPERIMENTAL): None
- JNJ-42160443 (higher dose) (Type: EXPERIMENTAL): None
- Oxycodone CR (standard pain medication) (Type: ACTIVE_COMPARATOR): None
- Placebo (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).